Crescent Biopharma Announces Grants of Inducement Awards
On May 12, 2026, Crescent Biopharma, Inc. in Waltham, Mass., announced that the Compensation Committee of its Board of Directors authorized the granting of options to acquire a total of 129,075 shares of the Company's ordinary shares to five non-executive employees. These options were given as equity inducement awards under the Crescent Biopharma, Inc. 2025 Employment Inducement Incentive Award Plan. The approval for these options was granted on May 11, 2026. This action was taken in compliance with Nasdaq Listing Rule 5635(c)(4) and was crucial for the acceptance of employment by each of the employees at Crescent.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments